Quality of Life in Presbyopic Patients Who Are Treated With Qlosi

Part of paid clinical trials in Medina, Minnesota.

Sponsor
Southern College of Optometry
Study ID
NCT07113210
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
45 Years - 64 Years
Healthy Volunteers
Not accepted

Interventions

  • pilocarpine HCL ophthalmic solution — DRUG
    Qlosi will be given to participants and quality of life will be determined.

Study Details

The goal of this clinical trial is to determine how Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%impacts the quality of life of participants with presbyopia by using a battery of validated and investigator-developed instruments * Improvement in presbyopic symptoms as measured with the Near Activity Visual Questionnaire-Presbyopia (NAVQ-P) when using Qlosi™ at week 4 compared to baseline (continuous variable). * Improvement in presbyopic symptoms as measured with the Visual Quality of Life with Time Survey (VisQualT) questionnaire when using Qlosi™ at week 4 compared to baseline.

Key Dates

Start date
Jul 18, 2025
Status verified
Aug 2025
Primary completion
Oct 31, 2025
Completion
Nov 15, 2025

Study Design

Enrollment
36 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Qlosi
    Subjects will be treated with Qlosi™ BID OD/OS, and subjects will only be allowed to use reading glasses for urgent work

Primary Outcome Measure

Near Visual Acuity Questionnaire-Presbyopia [ Time Frame: 1 month ]

Locations (2)

FacilityCityStateZIPSite coordinators
Complete Eye Care of MedinaMedinaMinnesota55340
Gina Wesley, OD
[email protected]
763-478-3505
The Southern College of OptometryMemphisTennessee38104
Chris Lievens, OD
[email protected]
9014815699

Find similar trials in Medina, MN

By research site
Complete Eye Care of Medina· Medina, MNThe Southern College of Optometry· Memphis, TN

Related Studies